Quinolone safety and efficacy more important than potency

被引：8

作者：

Frothingham, R

机构：

[1] Durham VA Med Ctr, Durham, NC 27705 USA

[2] Duke Univ, Med Ctr, Durham, NC 27706 USA

来源：

EMERGING INFECTIOUS DISEASES | 2004年 / 10卷 / 01期

关键词：

D O I：

10.3201/eid1001.030307

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：156 / 157

页数：2

共 10 条

[1] A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia [J].

File, TM ;

Segreti, J ;

Dunbar, L ;

Player, R ;

Kohler, R ;

Williams, RR ;

Kojak, C ;

Rubin, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) :1965-1972

[2] Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment [J].

Finch, R ;

Schürmann, D ;

Collins, O ;

Kubin, R ;

McGivern, J ;

Bobbaers, H ;

Izquierdo, JL ;

Nikolaides, P ;

Ogundare, F ;

Raz, R ;

Zuck, P ;

Hoeffken, G .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) :1746-1754

[3] Rates of Torsades de Pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin [J].

Frothingham, R .

PHARMACOTHERAPY, 2001, 21 (12) :1468-1472

[4] Timing of new black box warnings and withdrawals for prescription medications [J].

Lasser, KE ;

Allen, PD ;

Woolhandler, SJ ;

Himmelstein, DU ;

Wolfe, SN ;

Bor, DH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (17) :2215-2220

[5] Effects of three fluoroquinolones on QT interval in healthy adults after single doses [J].

Noel, GJ ;

Natarajan, J ;

Chien, SC ;

Hunt, TL ;

Goodman, DB ;

Abels, R .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (04) :292-303

[6]

Norrby SR, 1998, SCAND J INFECT DIS, V30, P397, DOI 10.1080/00365549850160710

[7]

Scheid MW, 2003, EMERG INFECT DIS, V9, P1

[8]

SHAFFER DN, 2003, MACROLIDE ANTIBIOTIC

[9]

2003, DRUG TOPICS, V60

[10]

2002, DRUG TOPICS, P38

← 1 →